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ABSTRACT
SYNTHESIS, CHARACTERIZATION, DNA BINDING AND PHOTOACTIVITY 
OF DIRUTHENATED C/S-5,10-(4-PYRIDYL)-15, 20-(PENTAFLUOROPHENYL)
PORPHYRIN.
Beeram Sandya Rani
University of Dayton
Advisor: Dr. Shawn. M. Swavey
The porphyrin 5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin (I) was 
synthesized by refluxing a solution of pentafluorobenzaldehyde, 4- 
pyridinecarboxaldehyde and pyrrole in propionic acid. The separation of c/s- 
porphyrin (I) from a mixture of six porphyrins was achieved by column 
chromatography. The porphyrin [5,10-(4-pyridyl)-15,20-(pentafluorophenyl) 
porphyrin Ru2(bipy)4Cl2](PF6)2 (II) was synthesized by reacting c/s-porphyrin (I) 
with c/s-Ru(bipy)2Cl2 in glacial acetic acid. Electronic transitions associated with 
c/s-porphyrin (I) consist of an intense Soret band at 410 nm and three Q bands 
from 500-650 nm. Coordination of [Ru(bipy)2CI]+ groups to the pyridyl nitrogens of 
the porphyrin give additional electronic transitions associated with bipy orbitals 
and metal to ligand charge transfer (MLCT) transitions attributed to Ru(II) and
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bipy orbitals. The cyclic voltammogram of c/s-porphyrin (I) shows two
quasireversible redox couples in the cathodic region which occur at E1/2 = -0.86 V 
and -1.26 V versus Ag/AgCI reference which are shifted to slightly more positive
potentials when the porphyrin is coordinated to the Ru(II) groups. Ruthenium
porphyrin (II) shows a quasireversible redox couple in the anodic region at 0.83 
V versus Ag/AgCI attributed to Ru(lll/Il) couple. Spectroscopic titrations were 
performed with calf thymus DNA to determine a binding constant (Kb) for c/'s- 
porphyrin (I) and ruthenium porphyrin (II). A binding constant of 7.6 x 105 M'1 
was determined for ruthenium porphyrin (II) and a value of 2.0 x 104 M'1 was 
determined for the c/s porphyrin (I). Irradiation of aqueous buffered solutions of
circular plasmid DNA and the ruthenium porphyrin (II) complex with a 50 W
tungsten-halogen lamp indicate, by gel electrophoresis, that light induced DNA 
photocleavage occurs.
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CHAPTER 1
INTRODUCTION
There has been a growing interest in Photodynamic therapy (PDT) as a 
treatment modality to destroy cancer cells.1 The first clinical application of PDT 
occurred in 1900 when Oscar Rabb, a medical student working with professor
Herman von Tappeiner noted that paramecium caudatum cells died quickly 
when exposed to light in the presence of acridine orange.2 In 1903, Jesionek 
and Tappeiner treated skin cancer with light and eosin.3 In these instances 
acridine orange and eosin act as photosensitizers. In 1913, Meyer-Betz 
observed the photosensitizing effects of porphyrins in man by injecting himself 
intravenously with hematoporphyrin and noticed pain and swelling in the light 
exposed area.4 The structures of the early photosensitizers are illustrated in 
Figure 1.
Figure 1: Early photosensitizers.
Acridine Hematoporphyrin
The uptake of porphyrins in significant amounts by tumors was first 
visualized by Policard in 1924 when he observed the characteristic red 
fluorescence of hematoporphyrin in experimental rat sarcoma illuminated with 
ultraviolet light.5 Together with Jadlbauer, von Tappeiner went on to 
demonstrate the requirement of oxygen in photosensitization reactions and in 
1907 introduced the term “photodynamic action” to describe the phenomenon.6
Three fundamental requirements for PDT are light, molecular oxygen 
and a photosensitizer. Each factor is harmless by itself but the combination of 
all three factors can result in the production of lethal cytotoxic agents that can 
destroy cancer cells.1
REACTION MECHANISMS OF PDT:
Porphyrin Molecular
Sensitizer Oxygen
Figure 2: Jablonski diagram.
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The photochemical and photophysical principles of PDT are schematically 
represented in the modified Jablonski diagram, (Figure 2).7 The photosensitizer 
has no effect on the tissue unless it is activated by light of an appropriate 
wavelength. The photosensitizer absorbs a photon of energy from the light 
source. Once it has absorbed energy the excited photosensitizer can return to 
the ground state by a number of pathways. A good photosensitizer at this stage 
undergoes intersystem crossing to get rapidly converted to the long lived triplet 
state. There are two mechanisms by which the triplet state photosensitizer can
react with biomolecules; these are known as the Type I and Type II reactions. In
Type I reactions there might be an hydrogen atom abstraction or electron
transfer reaction between the excited state of the sensitizer and the substrate to
yield radicals and radical ions. Since these radical species are highly reactive 
they can interact with molecular oxygen to generate reactive oxygen species 
(ROS) such as superoxide anion, hydrogen peroxide and hydroxyl radicals.
Type II reactions produce an excited and highly reactive state of oxygen known
as singlet oxygen. Direct interaction of the excited triplet state photosensitizer 
with molecular oxygen results in formation of reactive singlet oxygen. Singlet 
oxygen and ROS are oxidizing molecules that can readily react with biological 
molecules and they can oxidatively modify selected amino-acid residues, 
unsaturated lipids or damage DNA.8 Type II reactions are reported to dominate 
during PDT. However Type I reactions may become more dominant under
conditions where photosensitizers are highly concentrated, and especially under 
hypoxic conditions.9 These reaction types are illustrated in scheme 1.
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Scheme 1: Type I and Type II Reactions
Type I Reactions:
3P* + S -----------► P + S+ C1)
followed by + O2 SOx (2)
or
P~ + O2---------- ► Po + 67 (3)
O2 + S ► ^ox
In both cases giving an oxidized biomolecule Sox.
An alternate type I reaction pathway might be
3P*+ 3o2 -------- P + O2 (5)
+ •+ 
followed by P + S ---------► Po+ S (6)
Reaction (4) may follow after reaction (5) and reaction (2) may follow after 
reaction (6).
Type II Reactions:
3p* _|_ 3q^---------► Po + !O2
'o2 + S ------ *• sox
The first sensitizer used in clinical PDT was a Hematoporphyrin derivative 
and its purified fraction Photofrin HpD. Photofrin® has passed the clinical trials 
and it was the first PDT agent approved by FDA for treating esophageal cancer 
and is currently used to treat a wide variety of cancers.10 Photofrin® is a mixture 
containing hematoporphyrin, hydroxyl ethyl vinyl deuteron porphyrin (HVD) and
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protoporphyrin (Pp) as well as complex dimeric and oligomeric fractions.11 It has 
low quantum yields and low efficiency in the generation of reactive oxygen 
species. It results in prolonged skin photosensitivity lasting for 6-8 weeks.12 It is 
excited with red light at 630 nm. This wavelength can penetrate tissue to a depth 
of few mm and hence is unsuitable for treating deep seated tumors. New 
photosensitizers, so called “second generation” photosensitizers have been 
synthesized that have better properties than Photofrin®. Chlorins and 
Bacteriochlorins are a group of molecules very similar to porphyrins which were 
found to be effective photosensitizers in cancer prevention.13 In chlorins one of 
the exopyrrole double bonds of the porphyrin ring is hydrogenated and in 
bacteriochlorins, two of the exopyrrole double bonds of the porphyrin ring are 
hydrogenated thus enabling maximum absorption at longer wavelengths. The 
core structures of porphyrin, chlorin and bacteriochlorin are illustrated in Figure 3.
Porphyrin Chlorin bacteriochlorin
Figure 3: The basic chemical structures of porphyrins, chlorins and 
bacteriochlorins.
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Temoporfin or tetra (m- hydroxyl-phenyl) chlorin, Figure 4 under the trade 
name Foscan™ is a potent photosensitizer available for clinical use at present. 
This drug was approved by the European Union for the treatment of head and 
neck cancers in 2001. It is 200 times more effective than Photofrin®. It is 
activated with a longer wavelength and lower light intensity compared to 
Photofrin® and also has a longer half life in the triplet state generating more 
cytotoxic oxygen species.14 Foscan is also in clinical trials for late stage 
esophageal cancer and dysplasia in Barrett’s esophagus.15 It is more selective 
between tumor and normal tissue.
Figure 4: Structure of m-tetra hydroxyl phenyl chlorin.
Verteporfin (benzo-porphyrin-derivative mono-acid ring A), Figure 5, which
is a chlorin type molecule under the trade name Visudyne™ is in Phase III
clinical trials for cutaneous non-melanoma skin cancer and Phase I/II trials
against non-melanoma skin cancers (such as multiple non-melanoma skin 
cancer)16, psoriasis17 and psoriatic and rheumatoid arthritis. It has rapid tumor 
accumulation and reduced skin photosensitivity.18
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H3CO2C
h3cc
o
Figure 5: Structure of Verteporfin.
Pthalocyanines have emerged to be a promising class of second 
generation photosensitizers.19 The core consists of a tetra pyrrole unit, but in 
contrast to porphyrin, the pyrrole subunits are linked by nitrogen atoms rather 
than by methine bridges. This causes absorption spectrum to shift to longer 
wavelengths and hence increased tissue penetration.20 Incorporation of 
diamagnetic metals (Zn, Al) enables longer triplet state life times increasing the 
efficiency of the formation of reactive oxygen species. The basic structure of 
pthalocyanines is represented in Figure 6.
R
Figure 6: Structure of pthalocyanines.
RR
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Levulan (5-Aminolaevulinic Acid) has passed the clinical trials. It is a metabolic 
precursor in the biosynthesis of haem. Protoporphyrin IX (PplX) which is a 
natural photosensitizer is the immediate precursor to haem in this pathway. The 
rate of formation of PplX depends on the rate of synthesis of 5-Aminolaevulinic 
Acid (ALA) from glycine and succinyl CoA which is governed in negative 
feedback manner by concentration of free haem. The external addition of excess 
ALA can bypass this negative feedback, leading to a buildup of PplX, an effective 
photosensitizer for PDT.21
5-Aminolaevulinic acid Protoporphyrin IX
Figure 7 : 5- Aminolaevulinic acid (ALA) and Protoporphyrin IX.
co2h
The potential of porphyrins as anti tumor agents in oncology was first fully 
recognized in the 1960s with the development of hematoporphyrin derivative 
(HpD),which showed selective localization in solid tumors.22 Porphyrins are 
strongly colored compounds, the color is due to their electronic structure resulting 
in less intense absorptions at longer wavelengths (450 to 700 nm) in the visible 
region (called Q bands) and strong intense absorption in the near Ultra Violet
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region in the neighbourhood of 400 nm (called the Soret band). In 1884, Nencki 
isolated the first pure porphyrin by preparing Hematoporphyrin hydrochloride 
directly from isolated heme.23 In 1912, Kuster first proposed the structure of 
porphyrins as four pyrrole units linked by four methine bridges.24 The parent form 
of these tetrapyrrolic macrocycles is known as “porphine”, Figure 8.
Figure 8: Porphine: The parent form of tetrapyrrolic macrocycle.
In 1975, Dougherty demonstrated HpD could selectively destroy tumors
upon irradiation.25 Porphyrins were used as ideal photosensitizers because they 
generate singlet oxygen and have maximum absorption in the red portion of the 
electromagnetic spectrum which results in maximum penetration of light into the 
tissue.8 Most porphyrinoid photosensitizers have more than one absorption band 
and hence are used for tissue depth controlled penetration. In order to increase 
the quantum efficiency of photosensitizers such as porphyrins, fluorinated 
porphyrin derivatives, Figure 9 have been used. Enhanced triplet quantum yields 
are observed for fluorinated porphyrins which make them ideally suited to act as 
photosensitizers in photodynamic therapy.26 In addition to increased quantum 
efficiency pentafluorophenyl substituents have been utilized to covalently link 
sugars to porphyrins which improves the cell uptake.27
9
Figure 9: Structure of tetra-pentafluorophenyl porphyrin.
Metal complexes represent a promising field in the discovery of new PDT 
agents since they react with double stranded DNA directly from their excited 
state28,29 or via the production of various reactive species such as OH‘, O2" or 
1O2.30'31'32 Some examples of metal complexes that cleave DNA upon irradiation 
include mono nuclear Re(I)33, Ru(II)28, and Rh(III)34 complexes, dinuclear 
rhodium(II,II)35 and trinuclear Ru(II)-Rh(III)-Ru(II)36 complexes. The three main 
properties that make ruthenium complexes well suited to medicinal application 
are their rate of ligand exchange, range of accessible oxidation states and the 
ability of ruthenium to mimic iron in binding to certain biological molecules.37 
Intercalators are small molecules that contain a planar aromatic heterocyclic 
functionality which can insert and stack between the base pairs of double helical 
DNA.38 The early studies describing the intercalation of coordinatively saturated 
octahedral transition-metal complexes with DNA focused on the binding of 
tris(phenanthroline) complexes of zinc, cobalt and ruthenium to DNA, Figure 
10.39 Studies with these simple metal complexes provided a basis for
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understanding how octahedral complexes might interact noncovalently with DNA 
and also for exploring how the photophysical and redox characteristics of the 
metal complexes might be utilized in developing new probes for DNA.
2+
[R.u(tetra methyl phen)3]2+
Figure 10: Early octahedral DNA probes.
Increasing the surface area for intercalative stacking by a complex leads
to an increase in intercalative binding affinity. Bipyridyl and phenanthroline 
complexes of ruthenium containing the dipyrido[3,2-a:2’,3’-c]phenazine (dppz) 
ligand show good intercalation into the DNA.40 The dppz complexes, with their 
large aromatic surface area show extremely high affinity for DNA, with binding 
constants > 106 M'141 Analogous ruthenium complexes, with 1,4,5,8-
tetraazaphenanthrene (TAP), 1,4,5,8,9,12-hexaazatriphenylene (HAT) also 
interact with DNA and like dppz complexes, show changes in photophysical 
properties upon binding to the DNA duplex.42 Bimetallic complexes bridged by 
the 2,3-bis(2-pyridyl)-benzo quinoxaline (dpb) ligand have also been shown to 
bind to DNA by intercalation.43 The structures of dppz, TAP, HAT and dpb are 
illustrated in the Figure 11.
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dpb
Figure 11: Intercalating ligands.
Porphyrins containing meso substituted pyridyl groups are very well suited 
to coordinate metal complexes at the porphyrin periphery.44 The advantages of 
using polypyridyl ruthenium (II) substituents covalently linked to porphyrins are 
the added water solubility and the ability of ruthenium (II) polypyridyl complexes 
to intercalate and oxidize DNA bases resulting in decomposition 45 The present 
thesis describes the synthesis of 5,10-(4-pyridyl)-15,20-
(pentafluorophenyl)porphyrin [Figure 12(1)] and its ruthenium (II) analog [Figure
12(11)]. Characterization of these complexes is accomplished by UV-Vis 
spectroscopy, cyclic voltammetry, 1H NMR, time-of-flight mass spectrometry and 
elemental analysis. UV-Vis titrations of these porphyrins with calf thymus (CT) 
DNA were performed to determine the binding constant. Agarose gel
12
electrophoresis was performed to determine the photocleavage of circular 
plasmid (pUC18) DNA by ruthenium porphyrin [Figure 12(H)] after irradiation with 
a 50 W tungsten-halogen lamp.
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CHAPTER 2
EXPERIMENTAL SECTION
Materials
All reagents were analytical grade unless mentioned otherwise. 4- 
pyridinecarboxaldehyde, pentafluorobenzaldehyde, propionic acid, tetrabutyl 
ammonium hexafluorophosphate, TBAPF6, used as supporting electrolyte for 
electrochemistry and acetonitrile (extra dry < 50 ppm water) for electrochemistry 
were purchased from Acros Organics. Ammonium hydroxide, N,N’- dimethyl 
formamide (DMF), methanol, acetonitrile, diethyl ether, methylene chloride, 
ethanol, sea sand, glacial acetic acid and ethyl acetate were used from Fisher 
Scientific. (60-200 mesh) silica gel was obtained from Sorbent Technologies. 
Ruthenium (III) chloride trihydrate and 2,2’-bipyridine were obtained from 
Aldrich. Pyrrole (Aldrich) was vacuum distilled prior to use and all other reagents 
were used without further purification. Elemental analyses were performed by 
Atlantic Microlab, Norcross, Ga. High resolution mass spectroscopy was 
performed at the Mass Spectrometry and Proteomics facility, The Ohio State 
University.
Solution Electrochemistry
Solution cyclic voltammograms were recorded using a one compartment, three 
electrode cell, (model 630A Electrochemical analyzer from CH-lnstruments)
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equipped with a platinum wire auxiliary electrode. The working electrode was a 
2.0 mm diameter glassy carbon electrode from CH-lnstruments. The working 
electrode was polished initially using 0.30 p followed by 0.05 p alumina polish 
(CH-lnstruments) and then sonicated in distilled water for 5 sec prior to use. 
Potentials were referenced to a Ag/AgCI electrode, CH-lnstruments. The 
supporting electrolyte was 0.1 M tetrabutyl ammonium hexafluorophosphate 
(TBAPF6) and the measurements were made in extra dry, < 50 ppm water,
acetonitrile.
Electronic Spectroscopy
UV-Vis spectra were recorded at room temperature using a Schimadzu 
1501 photodiode array Spectrophotometer with 2 nm resolution. Samples were 
run in UV-grade CH3CN in 1 cm quartz cuvettes.
Proton NMR Spectroscopy
1H NMR spectra were recorded on a Bruker 300 MHz spectrophotometer 
using deuterated chloroform (CDCI3) as the solvent and tetramethylsilane (TMS)
as the internal standard.
Synthesis
c/s-Ru(bipy)?CI?:46
Bipyridine (3.00 gm, 19.0 mmoles) was dissolved initially in 15 mL of DMF 
and 2.80 gm (66.5 mmoles) of lithium chloride was added followed by 2.50 gm 
(9.50 mmoles) of RuCI3-3H2O and the reaction mixture was heated at reflux for 8
15
hours. The mixture was cooled to room temperature and poured into rapidly 
stirred 50 mL of acetone and the flask was rinsed with 2x12 mL portions of 
acetone. The mixture was cooled overnight and filtered giving a black/red 
powder which was sonicated in approximately 50 mL water and filtered again 
giving a microcrystalline powder which was washed with water until the filtrate 
was no longer orange followed by 3x20 mL diethyl ether and air dried. The 
product yield was 1.60 g (9.50 mmoles, 51 % yield).
5,10-(4-pyridyl)-15,2Q-(pentafluorophenvl)porphyrin \(cis- H?(DPyFP)1
A solution containing 1.9 mL (15 mmoles) of pentafluorobenzaldehyde and 
4.3 mL (45 mmoles) 4-pyridine carboxaldehyde in 100 mL of propionic acid was 
heated at reflux for 5 min. Freshly distilled pyrrole (4.2 mL, 60 mmoles) was
added to this solution and the reaction mixture was heated at reflux for 2 hr.
Upon cooling to room temperature the solution was divided into two fractions and 
each fraction was neutralized by cautious addition to a 100 mL 50:50 
methanol/ammonium hydroxide solution cooled in an ice bath. The slurry from 
both fractions was combined and allowed to precipitate for one day. The slurry 
was filtered and allowed to air dry. The fine powder was dissolved in 70-100 mL 
of ethanol and filtered and the precipitate was allowed to air dry. The powder was 
dissolved in methylene chloride and chromatographed on silica gel using ethyl 
acetate and ethyl alcohol in the ratio 50:50 as the eluent. The first band that 
came off the column was 5,15-(4-pyridyl)-10,20-(pentafluorophenyl)porphyrin. 
The second band was 5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin. The 
third band that came off the column was tri-pyrido mono-pentafluorophenyl
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porphyrin. The second band which was the desired band was collected and the 
solvent was removed by allowing it to evaporate. The product yield was 57.0 mg. 
(0.070 mmoles, 0.47% yield). Rf (ethyl acetate/ethanol 50:50) = 0.61.
UV-Vis (CH3CN) Amax (nm) [e x 10'4 (M’1 cm’1)] 410 [18.9], 507 [1.5], 581 [0.62], 
648 [0.26]. 1H NMR (300 MHz, CDCI3, TMS): 5 9.09 (4H, dd, 2,6-pyridyl), 8.90 
(4H, d, pyrrole), 8.86 (4H, d, pyrrole), 8.20 (4H, dd, 3,5-pyridyl), -2.92 (2H, s, 
internal pyrrole). [C42H18N6F10- 1C2H5OH] Anal Calcd (%): C, 62.71; H, 2.87; N, 
9.97; Found: C, 62.54; H, 3.05; N, 9.86%. TOF-MS ES+(m/z; relative 
abundance): [ C42Hi7N6F10]+ (796; 100).
[5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin Ru2(bipy)4CI21(PF6)2 [C/s- 
H2(DPyFP)Ru2(bipv)4Cl2l(PFg)?
A solution of 0.050 g (0.063 mmoles) of c/s-5,10-(4-pyridyl)-15,20- 
(pentafluorophenyl)porphyrin and 0.058 g (0.12 mmoles) of c/s-Ru(bipy)2CI2 was 
heated at reflux under nitrogen in 5 mL of glacial acetic acid for 45 min. The 
glacial acetic acid was removed under reduced pressure and the residue was 
taken up in a minimum (5 mL) of methanol and heated at reflux for 45 min. The 
reaction mixture was added dropwise to 60 mL of an aqueous solution of 
saturated ammonium hexafluorophosphate. The precipitate was filtered and 
washed with water. The powder was taken up in a minimum (5 mL) of 
acetonitrile and flash precipitated by addition to 100 mL of diethyl ether with 
stirring. The product was filtered and dried. The product yield was 0.050 gm. 
(0.025 mmoles, 40% yield). UV-Vis (CH3CN) Amax (nm) [e x 1CT4 (M‘1 cm’1)] 294 
[9.6], 411 [13.9],507 [2.8], 583 [0.9], [CszHsoN^C^Ri^- 4H2O] Anal Calcd
17
(%): C, 47.44; H, 2.71; N, 9.19; F, 20.03; Found: C, 47.30; H, 2.51; N, 9.37; F, 
19.83%. TOF-MS ES+ (m/z; relative abundance): [C82H5oNi4F22Cl2P2Ru2]+ (1839; 
46).
DNA INTERACTIONS
Materials:
Electrophoresis-grade low EEO agarose, tris(hydroxymethyl)- 
aminoethane (Tris), sodium chloride, and boric acid were obtained from Fisher. 
The plasmid, pUC18, was obtained from Bayou Biolabs. Ethidium bromide was 
obtained from EM. Agarose gel 6X loading dye was used to prepare the samples 
for loading on gel. The spectroscopic titration was carried out at room 
temperature in the buffer (5 mM Tris, 0.1 M NaCI, pH 7.16). Concentration of the 
calf thymus (CT) DNA (Sigma) solution used in titrations was determined 
spectrophotometrically using the extinction coefficient 6600 M'1cm'1at 260 nm.47 
All aqueous solutions were prepared using doubly distilled water. APEX 
illuminator (Oriel Inst., New port) was used to irradiate the samples. Electronic 
UV transilluminator (ULTRA. LUM. INC) was used for viewing DNA in agarose 
gels stained with ethidium bromide. Incubator (Barnstead labline) was used to 
incubate the samples in the experiments which were run in the dark. The pH of 
the solutions was measured using a Denver instruments pH meter.
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DNA binding titrations
Preparation of buffer (5 mM Tris, 0.1 M NaCI): 0.0610 g of tris(hydroxymethyl)- 
aminoethane (Tris) and 0.584 g of sodium chloride were weighed and dissolved 
in 100 mL of deionized water. The pH of the buffer was measured to be 7.16.
CT DNA was dissolved in buffer and the concentration of this solution was 
determined spectrophotometrically using the extinction coefficient 6600 M'1cm'1at 
260 nm giving a concentration of 330 pM.
A stock solution of ruthenium porphyrin (II) (19.5 pM) in 10% DMSO /H20 
was diluted to 9.75 pM using the Tris buffer solution. For DNA titrations 3.5 mL of 
the diluted ruthenium porphyrin was placed in a 1 cm quartz cuvette. Aliquots (10 
pL) of the CT-DNA solution were added to the cuvette and the Soret band 
associated with the ruthenium porphyrin (n) was monitored. Additions were 
made until the spectra did not change or the solution became turbid.
Photocleavage of circular plasmid DNA:
The5XTB buffer used for electrophoresis was prepared by dissolving 27.5 g 
Boric acid and 54.0 g Tris base in 1 L volumetric flask with deionized water. 
Preparation of agarose gel:
To 0.8 g of agarose weighed accurately , 80 mL of doubly distilled water 
was added and heated in a microwave for 2.5 min on low power. 20 mL of 5X TB 
buffer was added and swirled to mix well and then this liquid agarose solution 
was poured into the gel rig tray. An appropriate size comb was inserted into the 
liquid agarose and the gel was allowed to solidify. Once the gel solidified the 
buffer solution was added. The buffer was prepared by obtaining 150 mL of 5X
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TB buffer and diluting to 600 mL with doubly distilled water and then poured over 
the solidified gel.
Preparation of the metal complex:
10.1 pM ruthenium porphyrin (II) in 10 % DMSO was prepared and used for 
photocleavage studies.
Two solutions were prepared in 1.5 mL eppendorf tubes which includes 
one for control (DNA with no metal complex added) and other for the test (DNA 
with metal complex). 5 pL of 1 pg/1 pL pUC 18 DNA was added to both tubes. An 
appropriate amount of metal complex solution was added to the test solution to 
give the desired 5 DNA BP:metal complex ratio. An appropriate amount of doubly 
distilled water was added to both tubes to bring the final volume to 500 pL. Both 
tubes were vortexed and then spun in a centrifuge for 30 seconds. The control 
and test solutions were transferred to quartz cuvettes and placed side by side 
and irradiated with a 50 W tungsten halogen lamp from an APEX illuminator. At 
0, 30, 60, 90 and 120 minute time intervals 20 pL aliquots were pipetted into the 
eppendorf tubes. 4 pL of 6X loading dye was pipetted into each tube and all the 
10 tubes were vortexed and spinned in the centrifuge. The samples were then 
loaded onto the agarose gel and subjected to 150 V voltage for 1 hour. The gel 
was then soaked in ethidium bromide staining solution for 1 hour. The ethidium 
bromide staining solution was prepared by adding 30 pL of ethidium bromide to 
250 mL of deionized water and mixing well. The gel was then photographed 
using UV illumination.
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To reveal the importance of light, experiments were run in the absence 
and presence of light and a comparision was made. In this study two sets of 
solutions were prepared. Each set consists of a control and a test solution. 5 pL 
of pUC 18 DNA was added to both control and test solution. An appropriate 
amount of metal complex solution was added to the test solution to give the 
desired 5 DNA BP:metal complex ratio. Appropriate amount of doubly distilled 
water was added to both control and test solutions to bring the final volume to 
500 pL. Then one set of solutions was placed in an incubator at 37°C for 2 hours 
and the other set was irradiated for 2 hours with a 50 W tungsten halogen lamp 
from an APEX illuminator. The samples were loaded onto agarose gel and 
subjected to an electric field by applying 150 V voltage for 1 hour. The gel was 
then soaked in ethidium bromide staining solution for 1 hour and photographed 
using UV illumination.
21
CHAPTER 3
RESULTS AND DISCUSSION
Synthesis and characterization
The c/s-porphyrin (I) was synthesized by reaction of 
pentafluorobenzaldehyde, 4-pyridinecarboxaldehyde and pyrrole in the 
stoichiometric ratio 1:3:4 respectively in refluxing propionic acid, Figure 13.
Figure 13: Synthesis of 5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin.
The major product of this reaction is the polymeric material while the minor 
product is the formation of c/s-porphyrin (I) along with five other porphyrins,
Figure 14. Attempts to increase the yield of the c/s-porphyrin (I) by varying the 
ratio of the aldehydes led to the ratio shown in Figure 13 which indicates that 
pentafluorobenzaldehyde is more reactive than 4-pyridine carboxaldehyde. The 
polymeric byproducts were removed by washing with ethanol.
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Figure 14: Six different porphyrins resulted by reacting two different aldehydes 
with pyrrole in propionic acid.
Separation of the remaining six porphyrins was accomplished by column 
chromatography. Previous attempts to separate the six porphyrins by 
chromatographic separation using methylene chloride:acetone as the eluent 
were not successful in separating the cis/trans isomers. Hence different solvent
systems were employed to achieve the separation of the c/'s-porphyrin (I). The
crude product was dissolved in a minimal amount (ca 20 ml_) of methylene 
chloride and filtered to remove insoluble materials. The product solution was 
carefully added to the column and eluted with 50:50 ethyl acetate:ethanol which
23
resulted in the clean separation of the cis- porphyrin (I) as the second band. The 
yield of the product was very low and reported to be 0.47%. Thin layer 
chromatography was performed to determine the retention factor Rf for the cis 
porphyrin (I). The c/s-porphyrin (I) being more polar than the trans isomer 
possess lower Rf value (0.61) when compared to the frans-porphyrin (0.83) which 
was separated as the first band during the chromatographic separation. The 
mono-pyridyl tri-pentafluorophenyl porphyrin was washed along with the polymer 
and the tri-pyridyl mono-pentafluorophenyl porphyrin was separated as the third 
band. The cis- porphyrin (I) was characterized by 1H NMR, high resolution mass 
spectroscopy and elemental analysis.
Ruthenium porphyrin (II) was synthesized by adding the c/s-porphyrin (I) 
to c/s-Ru(bipy)2Cl2 in a stoichiometric ratio 1:2 and refluxing in glacial acetic 
acid, Figure15.
2 +
Figure 15: Synthesis of [5,10-(4-pyridyl)-15,20-(pentafluorophenyl)porphyrin- 
Ru2(bipy)4CI2]2+
II
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Substitution of the ruthenium polypyridyl complex to the peripheral pyridyl 
of the porphyrin involves displacement of a chloride ion from the sixth position. 
Since six coordinate Ru(ll) complexes are typically substitution inert, extreme 
conditions like refluxing in glacial acetic acid are required. After the acetic acid is 
removed under reduced pressure the resulting reaction mixture is refluxed and 
precipitated from methanol by addition of ammonium hexafluorophosphate. The 
product was isolated in descent yields and was characterized by high resolution 
mass spectroscopy and elemental analysis.
Electronic absorption spectroscopy:
The UV-Vis studies of the c/s-porphyrin (I) and its ruthenated analog (II)
were run in 1 cm quartz cuvettes in acetonitrile at room temperature. The UV- 
Visible absorption spectrum of a typical porphyrin exhibits an intense absorption 
at about 400 nm (the Soret band) followed by several weaker absorptions (Q 
bands) at higher wave lengths from 450 to 700 nm. Comparision of the electronic 
transitions of c/s-porphyrin (I) and its ruthenated analog (II) is illustrated in the
Figure 16. The c/s-porphyrin (I) (red line, Figure 16) shows an intense
absorption at 410 nm for the Soret band and three less intense Q bands at the 
wavelengths 506, 581 and 648 nm. The highest energy electronic absorption 
at 294 nm for the ruthenium porphyrin (II) is assigned as a bipy (tt- it*) 
intraligand charge transfer. Two shoulders at ca. 360 and 470 nm are attributed 
to Ru(dTT) - bipyCrr*) metal to ligand charge transfer (MLCT) transition. The 
details of these transitions and the molar absorptivities of the Soret and Q
bands of c/s porphyrin (I) and ruthenium porphyrin (II) are illustrated in Table 1.
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The electronic spectra of ruthenium porphyrin is an overlay of ruthenium spectra 
and porphyrin spectra separately. This indicates that there is very little electronic 
communication between ruthenium and porphyrin which would otherwise cause a
shift in the Soret band.
Figure 16: Electronic absorption spectra in acetonitrile at room temperature for 
cis porphyrin (I) (red) and ruthenium porphyrin (II) (blue).
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Table 1: Electronic absorption spectroscopy results for cis porphyrin (I) and 
ruthenium porphyrin (II).
Complex ^max (nm) £ x 104 M'1cm'1 Assignment
cis porphyrin 410 18.9 Soret (tt - tt*)
506 1.5 Q band
581 0.62 Q band
648 0.26 Q band
Ruthenium 294 9.6 bipy(TT) - bipyfnr*)
porphyrin 360 sh Ru(dTT) - bipy(TT*)
411 13.9 Soret (tt - tt*)
470 sh Ru(diT) - bipy(TT*)
507 2.8 Q band
583 0.9 Q band
Solution Electrochemistry
Solution phase cyclic voltammetry (CV) was performed using a one 
compartment, three electrode cell, equipped with a platinum wire auxiliary 
electrode. The working electrode was a 2.0 mm diameter glassy carbon 
electrode. Potentials were referenced to a Ag/AgCI electrode. The supporting 
electrolyte was 0.1 M tetrabutyl ammonium hexafluorophosphate (TBAPF6) and 
the measurements were made in extra dry, < 50 ppm water, acetonitrile, purged 
with N2 to remove oxygen from the solution. The cyclic voltammograms of the cis 
porphyrin (I) and its ruthenium analog (II) are illustrated in Figure 17.
When the cis- porphyrin (I) solution is cycled in the cathodic direction two 
quasireversible redox couples with E1/2 = -0.86 V and -1.26 V versus Ag/AgCI are 
observed. These redox couples can be associated with sequential reduction of
the porphyrin ring to form the radical anion. In the anodic direction there is a
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weak irreversible oxidation process at Epa = 1.15 V versus Ag/AgCI due to the 
porphyrin oxidation, Figure 17 (red line). Table 2 illustrates the redox potentials 
and their assignments.
When the ruthenium porphyrin (II) solution is cycled in the cathodic
direction two quasireversible redox couples with E1/2 = -0.80 and -1.18 V 
versus Ag/AgCI are observed which are attributed to a porphyrin centered redox 
process. In the anodic direction, a quasireversible redox couple with E1/2= 0.83 
V versus Ag/AgCI associated with the Ru(lll/Il) couple is observed, Figure 17 (blue 
line). The redox potentials in the cathodic region for ruthenium porphyrin (II) and
c/s-porphyrin (I) are very similar to each other. This indicates the fact that there
is very little electronic communication between ruthenium and porphyrin which 
would otherwise cause a greater difference in the redox potentials in the cathodic 
region than what is observed.
Table 2: Redox potentials and their assignments for c/s porphyrin (I) and 
ruthenium porphyrin (II).
Complex Ei/2(V) Assignment
C/'s-porphyrin -0.86
-1.26
Por °'-
Por ’/2'
Ruthenium
porphyrin
0.83
-0.80
-1.18
Ru1"1'"’
Por °'- 
Por -12'
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E/V vs. Ag/AgCI
Figure 17: Cyclic voltammograms of cis porphyrin (I) (red) and ruthenium 
porphyrin (II) (blue) in TBAPF6/Acetonitrile vs Ag/AgCI. Working electrode is 
glassy carbon with a scan rate of 100 mv/s, N2 atmosphere.
29
CHAPTER 4
DNA INTERACTIONS
There are several ways in which complexes can interact with DNA. 
Complexes can interact with DNA by covalently binding, electrostatically binding, 
groove binding or by intercalating. Studies on several compounds of ruthenium 
like [Ru(bpy)2L]2+ and [Ru(phen)2L]2+ where L is an aromatic bidentate ligand, 
indicate that these compounds bind to DNA, often in an intercalative fashion.48 
DNA binding constants, Kb are the most commonly used measures of DNA 
binding affinity. The association of metal complex with DNA is treated as a simple 
equilibrium, as shown in equation 1, where Mf is the free complex (in this case, 
ruthenium porphyrin), DNAf is free DNA, and MDNA is a bound ligand and bound 
binding site.
[Mf] + [DNAf] ■< **- [M+DNA] Equation 1
To determine quantitatively a binding constant (Kb) for the interaction of 
ruthenium porphyrin (II) with DNA, absorption titrations were used. Aqueous 
solutions of ruthenium porphyrin (II) which were 5% in DMSO were titrated with 
pH 7.16 buffered solutions (5 mM Tris, 0.1 M NaCI) of calf thymus (CT) DNA. 
The concentration of the ruthenium porphyrin (II) was 9.75 pM and the 
concentration of CT-DNA was 330 pM. 5 mM Tris, 0.1 M NaCI was used as the
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buffer solution. An aliquot of 10 pL DNA was added to the ruthenium porphyrin 
(II) and the absorbance of the Soret band was recorded. Figure 18 illustrates 
the effects of additions of 10 pL aliquots of CT-DNA on the absorbance of the 
Soret band associated with ruthenium porphyrin (II). As the concentration of 
CT-DNA increases the Soret band decreases and shifts to lower energy (415- 
423 nm). This red shift is indicative of intercalative binding to DNA.49
Figure 18: Absorption spectra of pH 7.16 buffer solutions of ruthenium porphyrin 
(II) in the presence of increasing amounts of CT-DNA. [ruthenium porphyrin (II)] 
= 9.75 pM.
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The intrinsic binding constant Kb for the CT-DNA ruthenium porphyrin 
interaction was determined from equation 2.50
[DNA]/ (ea- Cf) = [DNA]/ (eb- Cf) + 1/Kb(eb- Cf) Equation 2
where ea = absorbance/ [ruthenium porphyrin], eb and Cf are the extinction 
coefficients for the fully bound form and the extinction coefficient for the free form 
of ruthenium porphyrin(II), respectively. A linear fit of the plot of [DNA]/ (ea-Cf) 
versus [DNA] gives a slope of 1/(eb- ef) and an intercept of 1/ Kb(eb- ef), Figure 
19. The intrinsic binding constant Kb is given by the ratio of the slope to intercept.
|DNA] x 106
Figure 19: Plot of [DNA]/(£a-£f) versus [DNA]
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This half-reciprocal absorption titration method, which has been used 
successfully to determine the intrinsic Kb of molecules as hydrophobic as benzo 
pyrene derivatives, was found to provide a useful route to obtain intrinsic binding 
constant for the broad range of ruthenium complexes of different solubilities.51 A 
value of 7.6 x 105 M'1 was determined for ruthenium porphyrin (II) by this 
method. A value of 2.0 x 104 M’1 was determined for the c/s porphyrin (I) by this 
method. The magnitude of Kb coupled with the red shift of the Soret band 
suggests an intercalative process for the binding of ruthenium porphyrin (n) with 
DNA.49 The greater binding constant for ruthenium porphyrin (II) compared to cis 
porphyrin (I) is most likely due to the increased charge of the complex and
therefore is an effect of increased electrostatic attraction.
Photocleavage of circular plasmid DNA
Agarose gel electrophoresis was performed to determine the
photocleavage of circular plasmid DNA by ruthenium porphyrin (II). Gel
electrophoresis is a method for separating chemical compounds based on their 
size, shape and charge. Gel electrophoresis is used to identify distinct 
conformations of circular plasmid DNA. Supercoiled DNA (Form I), is the fastest 
moving conformation in the gel because of its compact shape. Nicked circular 
DNA (Form II) is also called relaxed circle and it is the slowest conformation of 
circular plasmid in the gel. In the nicked circular DNA, the superhelical tension 
relaxes and the tightly wound ball becomes a floppy circle. In electrophoresis 
experiments the DNA fragments are injected into the wells in solidified agarose
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gel and subjected to an electric field. Since the DNA is negatively charged the 
fragments that are loaded into a sample well at the cathode (-) end of a gel move 
through the gel towards the anode (+). The mobility of DNA fragments on the gel 
is dependent on the size, shape and the overall charge.
The DNA gels are made of agarose, a highly purified agar, which is 
heated and dissolved in a buffer solution. The agarose molecules form a matrix 
with pores. Agarose gels can be used to analyze double-stranded DNA 
fragments from 70-base-pairs (bp) (3% agarose gel, w/v) to 800,000 bp (0.1% 
agarose gel).52 In this project 0.8% agarose gel is used.
The solutions of circular plasmid DNA with and without ruthenium 
porphyrin (II) were placed in two different quartz cuvettes and irradiated with a 50 
W quartz tungsten halogen lamp for 120 minutes. At 30 min intervals aliquots of 
both solutions were removed and prepared for gel electrophoresis. Figure 20 
illustrates the results of the gel electrophoresis study.
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Figure 20: Gel electrophoresis results of circular plasmid DNA (pUC18) in the 
presence of ruthenium porphyrin (lanes 2, 4, 6, 8, 10) and without ruthenium 
porphyrin (lanes 1, 3, 5, 7, 9) irradiated with 50 W quartz tungsten halogen lamp 
for 0 min (lanes 1 and 2), 30 min (lanes 3 and 4), 60 min (lanes 5 and 6), 90 min 
(lanes 7 and 8) and 120 min (lanes 9 and 10).
When buffered solutions of circular plasmid DNA (pUC18) containing 
ruthenium porphyrin (II) in a ratio of 5:1 bp:ruthenium porphyrin, are irradiated 
with light the supercoiled DNA (Form I) is converted to nicked circular DNA (Form 
II). Lanes 1, 3, 5, 7 and 9 represent buffered solutions of pUC18 without 
ruthenium porphyrin (II) irradiated for 0, 30, 60, 90 and 120 min, respectively. 
Lanes 2, 4, 6, 8 and 10 represent buffered solutions of pUC 18 with ruthenium 
porphyrin (II) irradiated for 0, 30, 60, 90 and 120 min, respectively. Lanes 2, 4, 6,
8 and 10 illustrate a decrease of form I and an increase of form II. As the
irradiation time increases the circular DNA has been converted to nicked DNA.
After 2 hours of irradiation the plasmid DNA without ruthenium porphyrin (lane 9)
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remains unchanged while the circular plasmid DNA in the presence of ruthenium 
porphyrin (II) (lanelO) has been completely converted to the nicked form (Form 
II). Hence gel electrophoresis results suggests that the ruthenium porphyrin (II) 
can photolytically cleave circular DNA.
A B C D
Form II
Form I
Figure 21: Gel electrophoresis results both in the absence and presence of light. 
Lanes A and B represent the circular plasmid DNA (pUC18) in the absence and 
presence of ruthenium porphyrin respectively incubated for 2 hours at 37°C. 
Lanes C and D represent the circular plasmid DNA (pUC18) in the absence and 
presence of ruthenium porphyrin respectively irradiated with light for 2 hours.
To show that photocleavage of DNA requires both the ruthenium porphyrin 
and light, experiments were run in which solutions of pUC18 with and without 
ruthenium porphyrin (II) were irradiated for 2 hours. Simultaneously the same 
solutions were incubated in the dark for 2 hours followed by gel electrophoresis, 
Figure 21. Lanes A and B represent the circular plasmid DNA (pUC18) in the
absence and presence of ruthenium porphyrin (II) (5:1 bp:metal complex ratio)
36
respectively, incubated for 2 hours at 37°C. Lanes C and D represent the circular 
plasmid DNA (pUC18) in the absence and presence of ruthenium porphyrin (II) 
(5:1 bp:metal complex ratio) respectively irradiated with 50 W quartz tungsten 
halogen lamp for 2 hours. Lanes A ,B and C reveal no difference in the plasmid 
DNA where as in lane D the circular plasmid DNA has been converted to the 
nicked form (Form II). Hence the results reveal that the process is light induced.
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CHAPTER 5
CONCLUSIONS
This study describes the synthesis of two new complexes, 5,10-(4-pyridyl)-
15,20-(pentafluorophenyl)porphyrin (I) and 5,10-(4-pyridyl)-15,20-
(pentafluorophenyl)porphyrin Ru2(bipy)4Cl2 (II) and characterization of these 
complexes by UV-Vis spectroscopy, solution electrochemistry, 1H NMR, 
elemental analysis and high resolution mass spectroscopy. The intrinsic binding 
constant (Kb) for these complexes was determined by Spectroscopic titrations 
with calf thymus DNA. A value of 7.6 x 105 M'1 was determined for the 
ruthenium porphyrin (II) and a value of 2.0 x 104 M‘1 was determined for the c/s 
porphyrin (I). The magnitude of Kb coupled with the red shift of the Soret band
suggests an intercalative process for the binding of these complexes with DNA. 
Agarose gel electrophoresis was performed to determine the photocleavage of 
circular plasmid DNA by ruthenium porphyrin (II) and the results reveal that the 
ruthenium porphyrin (II) can photolytically cleave circular DNA.
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CHAPTER 6
FUTURE EXPERIMENTS
The present studies reveal that the ruthenium porphyrin (II) can 
photolytically cleave circular DNA. Further studies are underway to synthesize a 
tri-pyrido mono pentafluorophenyl ruthenated porphyrin and determine its 
photolytic cleavage of circular plasmid DNA. The proposed structure of porphyrin 
for future studies is illustrated in Figure 22.
Figure 22: Proposed structure of porphyrin for future study.
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